Anterogen.Co.,Ltd. Market Cap

Anterogen.Co.,Ltd. has a market cap or net worth of 254.15 billion as of August 8, 2025. Its market cap has increased by 60.62% in one year.

Market Cap

254.15B

Enterprise Value

210.12B

Revenue

7.00B

Ranking

n/a

PE Ratio

n/a

Stock Price

24,700.00

Market Cap Chart

Since February 15, 2016, Anterogen.Co.,Ltd.'s market cap has decreased from 291.82B to 254.15B, a decrease of -12.91%. That is a compound annual growth rate of -1.45%.

Market Cap History

Date	Market Cap	% Change
Aug 7, 2025	254.15B	38.26%
Dec 30, 2024	183.83B	10.53%
Dec 28, 2023	166.31B	16.26%
Dec 29, 2022	143.05B	-76.39%
Dec 30, 2021	605.82B	6.94%
Dec 30, 2020	566.53B	52.66%
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro
Feb 15, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	74.80T
Celltrion	39.20T
ALTEOGEN	23.73T
SK Biopharmaceuticals	8,724.10B
Yuhan	8,599.10B
Peptron	6,872.72B
HLB Co., Ltd.	6,237.58B
PharmaResearch	5,859.76B

Market Cap Rankings